
At AboGen, we believe that drawing large volumes of blood using invasive needles for research and diagnostic purposes does not fit with the 21st century. Founded in 2012, AboGen Inc. is the world's first company to show, through various independent 3rd party validators, that its technology can allow for the use of saliva, instead of blood, for various cell based research and diagnostic applications, including serological and genetic. We do not plan on replacing blood completely but we do plan on elevating saliva, as an alternative to blood for various cell based diagnostic applications, ABOve…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.